Why Anika Therapeutics Stock Crushed It Today
Better-than-expected Q2 earnings results spurred investors' interest in the small biotech.
Anika Therapeutics
ANIK
ANIK
$57.47
$1.26
2.2%
BATS BZX Real Time Price as of August 19, 2019, 4:00 p.m. EDT
View Interactive ANIK Charts
The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
News & Analysis: Anika Therapeutics
Anika Therapeutics Blows Past Q2 Earnings Estimates
Wall Street wasn't nearly as optimistic as it should have been about the biotech's second quarter.
Anika Therapeutics Inc (ANIK) Q2 2019 Earnings Call Transcript
ANIK earnings call for the period ending June 30, 2019.
Anika Therapeutics Inc (ANIK) Q1 2019 Earnings Call Transcript
ANIK earnings call for the period ending March 31, 2019.
Anika Therapeutics (ANIK) Q4 2018 Earnings Conference Call Transcript
ANIK earnings call for the period ending December 31, 2018.
Anika Therapeutics Inc (ANIK) Q3 2018 Earnings Conference Call Transcript
ANIK earnings call for the period ending September 30, 2018.
Why Pivotal Software, Anika Therapeutics, and Oracle Slumped Today
Find out which of these companies took the biggest hit.
Why Anika Therapeutics, Inc. Stock Is Sinking
Shares dropped after the company reported data from a late-stage trial. Here's what investors need to know.
3 Biotech Stocks to Buy in May
On the hunt for a biotech bargain? Our contributors think you should give these stocks a closer look.
3 Biotech Stocks to Buy in December
Three Motley Fool analysts tell investors which biotechnology stocks are on their wish list this month.
